LONDON (Reuters) – Britain could see widespread drugs shortages if there is no such thing as a deal to prevent friction on the border with the European Union after Brexit, the AstraZeneca chief govt instructed the Sunday Times.
FILE PHOTO: An indication is seen at an AstraZeneca web site in Macclesfield, central England May 19, 2014. REUTERS/Phil Noble/File Photo
The firm mentioned in July it could stockpile medication as a Brexit security web, and CEO Pascal Soriot instructed the Sunday Times in an interview that the complexity of the availability chain in prescribed drugs meant that delays could be probably.
“We have products that go back and forth between the UK and Europe at different stages of manufacturing,” he was quoted as saying. “If drugs are stuck, you have a problem.”
Separately, the Sunday Times reported that Jaguar Land Rover was contemplating following BMW’s lead and bringing ahead its annual summer season manufacturing facility shutdown to coincide with Britain’s departure from the EU in case there is no such thing as a deal, however added no determination had been taken.
Reporting by Alistair Smout; Editing by Sandra Maler